Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Amato

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Italian Journal of Neurological Sciences|June 1, 1988
Effectiveness of azathioprine treatment in multiple sclerosisL Fratiglioni, G F Siracusa, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohortE Portaccio, V Zipoli, G Siracusa, et al.
Journal of Autoimmunity|October 1, 1990
Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitusC Giordano, F Pantŏ, M P Amato, et al.
Neurology|April 1, 1993
Long-term safety of azathioprine therapy in multiple sclerosisM P Amato, G Pracucci, G Ponziani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosisV Zipoli, E Portaccio, G Siracusa, et al.
The Clinical Neuropsychologist|July 9, 2008
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosisE Portaccio, B Goretti, V Zipoli, et al.
Journal of Neurology|May 7, 2013
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patientE Piscolla, B Hakiki, L Pastò, et al.
Archives of Neurology|February 1, 1995
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-upM P Amato, G Ponziani, G Pracucci, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Quality of life in multiple sclerosis: the impact of depression, fatigue and disabilityM P Amato, G Ponziani, F Rossi, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Italian Journal of Neurological Sciences|June 1, 1988
Effectiveness of azathioprine treatment in multiple sclerosisL Fratiglioni, G F Siracusa, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohortE Portaccio, V Zipoli, G Siracusa, et al.
Journal of Autoimmunity|October 1, 1990
Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitusC Giordano, F Pantŏ, M P Amato, et al.
Neurology|April 1, 1993
Long-term safety of azathioprine therapy in multiple sclerosisM P Amato, G Pracucci, G Ponziani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosisV Zipoli, E Portaccio, G Siracusa, et al.
The Clinical Neuropsychologist|July 9, 2008
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosisE Portaccio, B Goretti, V Zipoli, et al.
Journal of Neurology|May 7, 2013
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patientE Piscolla, B Hakiki, L Pastò, et al.
Archives of Neurology|February 1, 1995
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-upM P Amato, G Ponziani, G Pracucci, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2001
Quality of life in multiple sclerosis: the impact of depression, fatigue and disabilityM P Amato, G Ponziani, F Rossi, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Pageof 11